Zantac / Ranitidine (NDMA Cancer) Attorney in Seattle, Washington

Zantac Litigation in Seattle

Washington state applies the Frye standard for novel scientific expert testimony — asking whether the methodology is generally accepted in the scientific community. This standard, similar to Delaware's and California's, may be more favorable for Zantac causation experts than the Daubert standard that closed the federal MDL. Washington's 3-year SOL provides additional time compared to most states. Seattle's sophisticated plaintiff bar and King County Superior Court experience with complex litigation make Washington a favorable state for Zantac claims. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.

Resources for Seattle Zantac Claimants

Seattle-area Zantac claimants should gather pharmacy records from Bartell Drugs (Washington-specific chain), Rite Aid, Walgreens, and QFC/Kroger pharmacies. Fred Hutch Cancer Center and UW Medicine records documenting bladder, esophageal, stomach, or colorectal cancer are critical evidence. Washington's 3-year SOL with the discovery rule provides a broader filing window than most states — but prompt legal consultation is still essential.